You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemodialysis,Hyperphosphatemia,Nicotinic Acids

Showing 1 - 25 of 4,434
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Diseases, Hemodialysis Complication, Hyperphosphatemia Trial in Cairo (Cholestyramine Resin 4000 MG [Questran],

Enrolling by invitation
  • Chronic Kidney Diseases
  • +2 more
  • Cholestyramine Resin 4000 MG [Questran]
  • Calcium Carbonate 500 MG Oral Tablet
  • Cairo, Egypt
    Ain Shams university
Oct 10, 2022

Hyperphosphatemia Patients on Hemodialysis Trial in Tokyo (TS-172 10mg bid, TS-172 30mg bid, TS-172 60mg bid)

Not yet recruiting
  • Hyperphosphatemia Patients on Hemodialysis
  • TS-172 10mg bid
  • +4 more
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Jan 23, 2023

Hyperphosphatemia Trial in China (VS-505, Sevelamer Carbonate)

Completed
  • Hyperphosphatemia
  • Beijing, Beijing, China
  • +22 more
Oct 17, 2022

av Fistula Patency Loss asCause of Fistula Failure and

Not yet recruiting
  • AV Fistula
  • doppler ultrasound
  • Assiut, Egypt
    Faculty of Medicine Assiut U
Oct 3, 2022

Chronic Kidney Diseases, Hyperphosphatemia Trial in Chengdu (AP-306, Sevelamer Carbonate)

Recruiting
  • Chronic Kidney Diseases
  • Hyperphosphatemia
  • Chengdu, Sichuan, China
    Sichuan Provincial People's Hospital
Mar 9, 2023

End Stage Renal Disease Trial (Valine, EEA)

Not yet recruiting
  • End Stage Renal Disease
  • (no location specified)
Jan 21, 2023

Phosphorus Metabolism Disorders, Acid-Base Balance Disorder Trial in Warsaw (Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35

Completed
  • Phosphorus Metabolism Disorders
  • Acid-Base Balance Disorder
  • Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35 mmol/L
  • Group 2: C) Dbic 30 -35 mmol/L B) Dbic 35- 30 mmol/L
  • Warsaw, Poland
    Wieliczko Monika
May 21, 2023

Hyperphosphatemia Trial in Kanoya (KHK7791)

Active, not recruiting
  • Hyperphosphatemia
  • Kanoya, Kagoshima, Japan
    Medical Corporation Seijinkai Ikeda Hospital
Sep 7, 2021

Hyperphosphatemia Trial in Tsukuba (KHK7791, Placebo)

Completed
  • Hyperphosphatemia
  • Tsukuba, Ibaraki, Japan
    Kikuchi medical clinic
Sep 7, 2021

Hyperphosphatemia Trial in Changchun (Lanthanum Polystyrene Sulphonate Powder, Lanthanum Carbonate 500 MG, Placebo)

Recruiting
  • Hyperphosphatemia
  • Lanthanum Polystyrene Sulphonate Powder
  • +2 more
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 27, 2021

Hyperphosphatemia Trial in Suita (KHK7791, Placebo)

Completed
  • Hyperphosphatemia
  • Suita, Osaka, Japan
    Inoue Hospital
Oct 26, 2021

Fatty Acid Metabolism, Erythrocytes, Lipidomics Trial in Berlin (Blood sampling)

Completed
  • Fatty Acid Metabolism
  • +3 more
  • Blood sampling
  • Berlin, Germany
    Charité University Experimental & Clinical Research Center
Mar 8, 2022

To Evaluate the Clearance Rate of Uremic Toxin by HFR Trial (HFR)

Not yet recruiting
  • To Evaluate the Clearance Rate of Uremic Toxin by HFR
  • HFR
  • (no location specified)
Aug 15, 2023

Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Lauderdale Lakes (Tenapanor)

Completed
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Hyperphosphatemia
  • Lauderdale Lakes, Florida
    South Florida Research Institute
Sep 28, 2022

Impact of IDPN on Nutrition Markers in Patients Receiving ICHD

Not yet recruiting
  • End-stage Renal Disease
  • Malnutrition; Protein
  • Intradialytic Parenteral Nutrition
  • Pompano Beach, Florida
    Patient Care America
Jun 27, 2022

Parkinson Disease, Mild Cognitive Impairment Trial in Stavanger (AZD0328, Placebo)

Withdrawn
  • Parkinson Disease
  • Mild Cognitive Impairment
  • (no location specified)
Oct 11, 2022

Chronic Kidney Diseases Trial in Bandung (Aerobic Exercise)

Recruiting
  • Chronic Kidney Diseases
  • Aerobic Exercise
  • Bandung, West Java, Indonesia
    Al Ihsan Hospital
Nov 13, 2023

Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release

Recruiting
  • Migraine Prophylaxis
  • Nicotinic Acid 500 MG Extended Release Oral Tablet
  • +2 more
  • Dhaka, Bangladesh
    BSMMU
May 5, 2023

Dialysis Adequacy in Nutritional Status in Hemodialysis Patients

Not yet recruiting
  • Dialysis Adequacy
  • Hemodialysis machine
  • (no location specified)
Oct 25, 2023

Maintenance Hemodialysis, Hyperphosphatemia Trial in Shanghai (Phosphate-binder intervention, Phosphorus-restricted dietary

Completed
  • Maintenance Hemodialysis
  • Hyperphosphatemia
  • Phosphate-binder intervention
  • Phosphorus-restricted dietary intervention
  • Shanghai, Shanghai, China
  • +1 more
Aug 25, 2021

Metabolic Syndrome, Hypertriglyceridemia Trial in Sioux Falls (omega-3 acid ethyl esters, extended release niacin, )

Completed
Has Results
  • Metabolic Syndrome
  • Hypertriglyceridemia
  • omega-3 acid ethyl esters
  • +3 more
  • Sioux Falls, South Dakota
    Sanford Clinic Clinical Research Services
Sep 28, 2021

Kidney Disease, End-Stage Trial in Kitchener (Qidni/D Hemodialysis System)

Recruiting
  • Kidney Disease, End-Stage
  • Qidni/D Hemodialysis System
  • Kitchener, Ontario, Canada
    Qidni Labs
Oct 10, 2023

Hyperphosphatemia, End Stage Renal Disease, ESRD Trial in China (Ferric Citrate, Sevelamer Carbonate)

Completed
  • Hyperphosphatemia
  • +2 more
  • Ferric Citrate
  • Sevelamer Carbonate
  • Baotou, China
  • +23 more
Mar 8, 2021

Sarcopenia Trial in Daejeon (exercise and nutritional support)

Not yet recruiting
  • Sarcopenia
  • exercise and nutritional support
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
May 30, 2023

Uremia Trial in Beijing (OCI-HF160, FX800HDF)

Completed
  • Uremia
  • OCI-HF160
  • FX800HDF
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Jun 1, 2023